GlaxoSmithKline To Conduct Clinical Study Of HPV Vaccine

Tokyo, Mar 16, 2006 (JCN) - GlaxoSmithKline (GSK) K.K. announced on March 14 that it will undertake a clinical study of a preventive vaccine for human papillomavirus (HPV) infection starting in April.
MORE ON THIS TOPIC